Vagus Nerve Stimulation for Myelopathy

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT07660250
Status
Recruiting

Conditions

  • Degenerative Cervical Myelopathy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Vagus nerve stimulation (taVNS) — DEVICE
    Vagus nerve stimulation - clip is attached to ear
  • Sham Stimulation — DEVICE
    Clip will be attached to the ear, but no stimulation will be given.

Study Details

The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)

Key Dates

Start date
Apr 14, 2026
Status verified
Jun 2026
Primary completion
Apr 30, 2028
Completion
May 31, 2028

Study Design

Enrollment
36 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Pre-Post Group (P-P)
    This group will undergo taVNS for up to 6 weeks before and for 3 months following surgery
  • Experimental: Post Group
    This group will undergo sham stimulation for up to 6 weeks before surgery. They will receive taVNS for 3 months after surgery
  • Sham Comparator: Sham Group
    This group will undergo sham stimulation for up to 6 weeks before surgery and for 3 months after surgery. The patients will not know they are not receiving stimulation.

Primary Outcome Measure

mJOA - Modified Japanese Orthopedics Association [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington UniversitySt LouisMissouri63110
Linda Z Koester, BS
314-362-7368
Wilson Z Ray, MD
Wilson Z. Ray, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in St Louis, MO

Related Studies